SL
WST icon

Salomon & Ludwin’s West Pharmaceutical WST Stock Holding History

Salomon & Ludwin’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.21K Hold
17
– – ﹤0.01% 1762
2026
Q1 		$4.33K Sell
17
-31
-65% -$7.71K ﹤0.01% 1795
2025
Q4 		$13.4K Sell
48
-1
-2% -$274 ﹤0.01% 1225
2025
Q3 		$13.4K Buy
+49
New +$11.9K ﹤0.01% 1099

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Salomon & Ludwin's WST Position: Q2 2026 in Review

Salomon & Ludwin held its West Pharmaceutical (WST) position steady in Q2 2026 at 17 shares worth $6.21K. The position accounts for ﹤0.01% of the portfolio, ranked #1762.

Salomon & Ludwin first reported a position in WST in Q3 2025 and has held it in 4 quarters since. The position peaked at $13.4K in Q4 2025. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Salomon & Ludwin held 17 shares of West Pharmaceutical worth $6.21K as of Q2 2026.
  • Salomon & Ludwin left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1762 holding.
  • Salomon & Ludwin first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • Salomon & Ludwin's West Pharmaceutical position peaked at $13.4K in Q4 2025.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.